GO:1990752 microtubule end: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990752 microtubule end is a cellular component term describing either end of a microtubule, with the plus-end preferentially growing by polymerization and the minus-end being less dynamic.
• Microtubule ends are not bare; they are bound by plus-end tracking proteins (+TIPs) and minus-end targeting proteins (-TIPs) that regulate dynamics and interactions.
• The distinct biochemical and structural properties of plus- and minus-ends are critical for spindle assembly, chromosome segregation, cell polarity, and intracellular transport.
• Dysregulation of microtubule-end associated proteins is linked to cancer, neurodegeneration, and developmental disorders.
• Key experimental approaches to study microtubule ends include live-cell imaging of EB proteins, in vitro reconstitution, and CRISPR-based knockout or knock-in of end-binding proteins.
• EDITGENE provides CRISPR services to generate knockout, point-mutation, knock-in, and overexpression cell models for studying microtubule-end biology.
Description
Microtubules are dynamic polymers of alpha- and beta-tubulin that form the cytoskeleton and are essential for cell shape, division, and intracellular transport. The term microtubule end (GO:1990752) refers to either extremity of a microtubule, but the two ends are structurally and functionally distinct: the plus-end is the fast-growing end that preferentially adds tubulin dimers, while the minus-end is the slow-growing or stable end, often anchored at microtubule-organizing centers. This asymmetry is fundamental to microtubule function and is exploited by cells to direct polymerization and depolymerization in space and time. Researchers study microtubule ends to understand how cells build and remodel their cytoskeleton, how chromosomes are segregated during mitosis, and how defects in these processes lead to disease. The plus-end is tracked by a diverse set of proteins known as plus-end tracking proteins (+TIPs), which include end-binding (EB) proteins, CLIP-170, and dynein/dynactin, while the minus-end is regulated by proteins such as CAMSAPs, Patronin, and MCAK. These proteins control microtubule dynamics, link microtubules to cellular structures, and mediate interactions with cargo and signaling molecules. Understanding the molecular composition and regulation of microtubule ends is therefore central to cell biology and has direct implications for cancer, neurodevelopment, and regenerative medicine.
microtubule end At A Glance
| GO ID | GO:1990752 |
|---|---|
| GO term | microtubule end |
| Ontology | cellular_component |
| Synonym | none |
| Major function | Site of tubulin polymerization/depolymerization and protein interactions that regulate microtubule dynamics and function |
| Plus-end characteristics | Preferentially grows by polymerization; tracked by +TIPs such as EB proteins |
| Minus-end characteristics | Less dynamic; often anchored; regulated by -TIPs such as CAMSAPs |
| Associated cellular processes | Mitosis, intracellular transport, cell polarity, neuronal development |
| Disease relevance | Cancer, neurodegeneration, developmental disorders |
What Is GO:1990752?
According to the Gene Ontology, microtubule end (GO:1990752) is defined as any end of a microtubule. The definition highlights that microtubule ends differ: the so-called microtubule plus-end is the one that preferentially grows by polymerization, with respect to the minus-end. This term is a cellular component and captures the structural and functional polarity of microtubules, which is essential for their role in the cytoskeleton.
Why Is microtubule end Important in Cell Biology?
Microtubule ends are the primary sites where microtubule dynamics are controlled, and they serve as hubs for protein-protein interactions that link microtubules to diverse cellular functions. Because the plus- and minus-ends have distinct properties, they are targeted by different regulatory proteins, allowing the cell to precisely control microtubule growth, shrinkage, and organization. Defects in microtubule-end regulation can lead to errors in chromosome segregation, impaired neuronal development, and cancer progression. Thus, studying microtubule ends is essential for understanding fundamental cell biology and for developing therapeutic strategies that target microtubule dynamics.
• Microtubule ends are the sites of tubulin addition and loss, making them central to cytoskeletal dynamics.
• Plus-end tracking proteins (+TIPs) regulate microtubule growth and link microtubules to cellular structures.
• Minus-end targeting proteins (-TIPs) control microtubule nucleation, anchoring, and stability.
• Microtubule ends are critical for mitotic spindle assembly and chromosome segregation.
• They are involved in neuronal development and maintenance, with defects linked to neurodegeneration.
• Dysregulation of microtubule-end proteins is associated with cancer cell proliferation and metastasis.
• Microtubule ends are targets for chemotherapeutic drugs such as taxanes and vinca alkaloids.
• Understanding microtubule ends aids in the development of targeted therapies for cancer and neurological disorders.
Structure and Composition of microtubule end
Plus-end structure and dynamics
In simple terms: The plus-end is the fast-growing end of a microtubule, where tubulin dimers are added most rapidly.
The plus-end of a microtubule is characterized by a beta-tubulin subunit exposed at the tip, which favors the addition of GTP-bound tubulin dimers. This end is dynamically unstable, alternating between phases of growth and shrinkage, a behavior known as dynamic instability. Plus-end tracking proteins (+TIPs) specifically recognize the plus-end and regulate its dynamics. End-binding (EB) proteins are core +TIPs that autonomously track the plus-end and recruit other +TIPs such as CLIP-170 and dynein/dynactin. These interactions allow the plus-end to act as a signaling hub that connects microtubules to cellular targets, including kinetochores and the cell cortex.
Minus-end structure and regulation
In simple terms: The minus-end is the slow-growing end, often anchored and stabilized by specific proteins.
The minus-end of a microtubule exposes an alpha-tubulin subunit and is generally less dynamic than the plus-end. It is often embedded in microtubule-organizing centers (MTOCs) such as centrosomes, where it is nucleated and anchored. Minus-end targeting proteins (-TIPs), including CAMSAPs (calmodulin-regulated spectrin-associated proteins) and Patronin, bind to the minus-end and protect it from depolymerization, thereby regulating microtubule stability and organization. These proteins are essential for non-centrosomal microtubule arrays in differentiated cells, such as neurons and epithelial cells.
Tubulin subunits and lattice structure
In simple terms: Microtubules are hollow tubes made of tubulin proteins, and their ends are the open extremities of these tubes.
Microtubules are composed of alpha- and beta-tubulin heterodimers that assemble into linear protofilaments, typically 13 in number, which form a hollow cylinder. The ends of this cylinder are the plus- and minus-ends. The structural polarity of the tubulin dimer, with beta-tubulin facing the plus-end and alpha-tubulin facing the minus-end, underlies the functional differences between the two ends. The GTP bound to beta-tubulin is hydrolyzed to GDP after polymerization, and this hydrolysis is thought to regulate the stability of the microtubule lattice and the transitions between growth and shrinkage.
Accessory proteins and post-translational modifications
In simple terms: Various proteins and chemical modifications on tubulin affect how microtubule ends behave.
Microtubule ends are regulated by a variety of accessory proteins, including motor proteins like kinesins and dynein, which can influence end dynamics by exerting forces or transporting cargo. Additionally, tubulin post-translational modifications, such as detyrosination, acetylation, and polyglutamylation, can affect the recruitment of +TIPs and -TIPs to microtubule ends, thereby modulating their properties. These modifications create a code that fine-tunes microtubule-end function in different cellular contexts.
Key Genes Involved in GO:1990752 microtubule end
The following genes encode proteins that localize to or regulate microtubule ends and are commonly studied in the context of GO:1990752.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAPRE1 (EB1) | Core plus-end tracking protein; regulates microtubule dynamics and recruits other +TIPs | Knockout leads to mitotic defects and impaired cell migration |
| MAPRE2 (EB2) | Plus-end tracking protein; involved in neuronal development | Mutations linked to neurodevelopmental disorders |
| MAPRE3 (EB3) | Plus-end tracking protein; enriched in neurons | Studied for roles in synaptic plasticity and neurodegeneration |
| CLIP1 (CLIP-170) | Plus-end tracking protein; links microtubules to endosomes and kinetochores | Knockdown affects chromosome alignment and cell polarity |
| DCTN1 (p150glued) | Component of dynactin; tracks plus-ends and mediates dynein-dependent transport | Mutations cause Perry syndrome and motor neuron disease |
| CAMSAP1 | Minus-end targeting protein; stabilizes minus-ends | Knockout disrupts non-centrosomal microtubule arrays |
| CAMSAP2 | Minus-end targeting protein; regulates microtubule stability | Implicated in neuronal development and migration |
| CAMSAP3 | Minus-end targeting protein; important for epithelial cell polarity | Knockout leads to defects in tight junction formation |
| KIF2A | Kinesin-13 motor; depolymerizes microtubule ends | Inhibition causes spindle defects and cancer cell death |
| KIF2C (MCAK) | Kinesin-13 motor; regulates kinetochore-microtubule attachment | Overexpression associated with chemoresistance |
| KIF18A | Kinesin-8 motor; regulates microtubule plus-end dynamics | Required for chromosome congression; target for cancer therapy |
| TUBB | Beta-tubulin; building block of microtubules | Mutations cause tubulinopathies and affect drug response |
| TUBA1A | Alpha-tubulin; building block of microtubules | Mutations linked to lissencephaly and brain malformations |
| STMN1 (Stathmin) | Microtubule destabilizer; increases catastrophe frequency | Overexpressed in many cancers; target for inhibition |
| MAPT (Tau) | Microtubule-associated protein; stabilizes microtubules | Hyperphosphorylation leads to neurofibrillary tangles in Alzheimer's disease |
| SPAST | Microtubule-severing protein; regulates microtubule ends | Mutations cause hereditary spastic paraplegia |
| KATNA1 | Katanin catalytic subunit; severs microtubules at ends | Regulates spindle and neuronal microtubule dynamics |
| TPPP | Tubulin polymerization promoting protein; bundles microtubules | Involved in oligodendrocyte differentiation and neurodegeneration |
How Is microtubule end Regulated?
Microtubule-end dynamics are regulated by a complex interplay of proteins and post-translational modifications. Plus-end tracking proteins (+TIPs) such as EB1 are recruited to the plus-end through recognition of a structural feature of the microtubule lattice, and their binding is modulated by phosphorylation and other modifications. Minus-end targeting proteins (e.g., CAMSAPs) are regulated by calmodulin and other factors to control minus-end stability. Motor proteins like kinesin-13 and kinesin-8 can depolymerize or stabilize ends in a force-dependent manner. Additionally, signaling pathways such as Aurora kinases and Rho GTPases influence microtubule-end behavior during mitosis and cell migration. The integration of these regulatory inputs ensures proper microtubule organization in space and time.
microtubule end and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MAPRE1 (EB1) | Cancer progression, metastasis | Knockout and overexpression in cancer cell lines; xenograft models |
| MAPT (Tau) | Alzheimer's disease, tauopathies | Knock-in of human mutant Tau in mice; neuronal cultures |
| TUBA1A | Tubulinopathies, lissencephaly | Patient-derived iPSCs; CRISPR-corrected isogenic lines |
| SPAST | Hereditary spastic paraplegia | Knockout mice; motor neuron differentiation from iPSCs |
| KIF2C (MCAK) | Cancer chemoresistance | Knockout in resistant cell lines; drug sensitivity assays |
Cancer
Altered expression or mutation of microtubule-end proteins is frequently observed in cancer. For example, overexpression of EB1 (MAPRE1) is associated with poor prognosis in several cancers and promotes cell migration and invasion. Kinesin-13 motor KIF2C (MCAK) is overexpressed in some tumors and contributes to chemoresistance by regulating kinetochore-microtubule attachments. Targeting microtubule-end regulators is a promising strategy for cancer therapy, as they are essential for mitotic spindle function and cell division.
Neurodegenerative diseases
Neurons rely heavily on microtubule ends for axonal transport and synaptic function. Mutations in plus-end tracking proteins such as MAPRE2 and DCTN1 have been linked to neurodevelopmental disorders and motor neuron disease. Hyperphosphorylation of Tau (MAPT), a microtubule-associated protein, disrupts microtubule stability and is a hallmark of Alzheimer's disease. Dysfunction of minus-end targeting proteins like CAMSAP2 has also been implicated in neuronal migration defects.
Developmental disorders
Tubulin gene mutations (e.g., TUBA1A, TUBB) cause a spectrum of brain malformations known as tubulinopathies, characterized by defective neuronal migration and differentiation. These mutations often affect microtubule dynamics at the ends, highlighting the importance of microtubule-end regulation in development. Additionally, mutations in SPAST, a microtubule-severing protein, lead to hereditary spastic paraplegia by disrupting microtubule-end dynamics in long axons.
From microtubule end-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of EB1 affect mitotic spindle assembly? | MAPRE1 knockout cell lines (e.g., HeLa, RPE1) |
| How does CAMSAP2 stabilize minus-ends in neurons? | CAMSAP2 knockout or knock-in of tagged CAMSAP2 in primary neurons |
| What is the effect of Tau mutations on microtubule dynamics? | Knock-in of mutant MAPT in human iPSC-derived neurons |
| Can overexpression of MCAK confer chemoresistance? | Overexpression of KIF2C in cancer cell lines followed by drug treatment |
| What are the interaction partners of CLIP-170 at plus-ends? | Knock-in of GFP-CLIP1 for proximity labeling and live imaging |
| Does KIF18A inhibition selectively kill cancer cells? | KIF18A knockout in cancer cell lines and normal cells; viability assays |
How to Study the microtubule end Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell TIRF microscopy | Microtubule dynamics and +TIP tracking in real time | Analyzing EB1 comet speed and lifetime |
| In vitro reconstitution | Effects of purified proteins on microtubule growth/shrinkage | Testing CAMSAP-mediated minus-end stabilization |
| CRISPR knockout screens | Genes required for viability or drug sensitivity | Identifying synthetic lethal partners of KIF18A |
| Proximity labeling (BioID) | Protein-protein interactions at microtubule ends | Mapping the CLIP-170 interactome |
| Phosphoproteomics | Signaling events that regulate end-binding proteins | Identifying Aurora kinase substrates at kinetochores |
| Electron microscopy | Ultrastructure of microtubule ends and protofilaments | Visualizing minus-end capping by CAMSAP |
Live-cell imaging of microtubule ends
Fluorescently labeled plus-end tracking proteins (e.g., EB1-GFP) or tubulin probes allow real-time visualization of microtubule dynamics in living cells. This method reveals growth rates, catastrophe and rescue frequencies, and the localization of end-binding proteins. Advanced techniques such as total internal reflection fluorescence (TIRF) microscopy enable single-molecule analysis of protein interactions at microtubule ends.
In vitro reconstitution assays
Purified tubulin and recombinant proteins can be combined in vitro to study microtubule nucleation, dynamics, and the effects of end-binding proteins. These assays provide precise control over conditions and allow mechanistic dissection of protein function at the ends. For example, the addition of EB1 to dynamic microtubules increases the duration of growth phases.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate microtubule-end dynamics or that are required for cell survival when microtubule-end proteins are perturbed. Such screens have uncovered synthetic lethal interactions with kinesin motors and plus-end tracking proteins.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry (AP-MS) or proximity-dependent biotinylation (BioID) can identify proteins that interact with microtubule-end components. These approaches have revealed the complex network of +TIPs and -TIPs and their dynamic associations.
How CRISPR Can Be Used to Study GO:1990752 microtubule end
Knockout
CRISPR knockout of genes encoding microtubule-end proteins (e.g., MAPRE1, CAMSAP2) allows researchers to assess their loss-of-function phenotypes. Knockout cell lines can be used to study mitotic defects, changes in microtubule dynamics, and altered responses to drugs. For example, MAPRE1 knockout leads to spindle misorientation and chromosome misalignment.
Point Mutation
Introducing specific point mutations into genes such as TUBA1A or MAPT can mimic disease-associated variants. These models help dissect how single amino acid changes affect microtubule-end dynamics and protein interactions. For instance, tubulin mutations found in patients with brain malformations can be knocked into cell lines to study their effects on microtubule stability.
Knock-in
Knock-in of fluorescent tags (e.g., GFP, mCherry) or epitope tags into endogenous loci enables real-time imaging and biochemical analysis of microtubule-end proteins at physiological expression levels. Tagged knock-in models are valuable for tracking protein localization and dynamics without overexpression artifacts.
Overexpression
Overexpression of microtubule-end proteins or their mutants can reveal gain-of-function phenotypes and dominant-negative effects. For example, overexpression of MCAK (KIF2C) increases microtubule depolymerization and can cause mitotic arrest. Overexpression models are also useful for testing drug resistance mechanisms.
How EDITGENE Supports microtubule end Research
Researchers studying microtubule end-related genes often need to determine whether a candidate gene is causally involved in microtubule dynamics, cell division, or disease. Generating precise genetic models is essential to move from correlation to causation. EDITGENE provides a comprehensive suite of CRISPR services to create knockout, point-mutation, knock-in, and overexpression cell models, as well as library screening and bioinformatics support, enabling rigorous investigation of microtubule-end biology.
Contact EDITGENE today to design your custom CRISPR model for microtubule end research.
Frequently Asked Questions About microtubule end
What is GO:1990752 microtubule end?
GO:1990752 is a Gene Ontology cellular component term that describes any end of a microtubule. The plus-end preferentially grows by polymerization, while the minus-end is less dynamic.
What genes are involved in microtubule end regulation?
Key genes include MAPRE1 (EB1), MAPRE2, MAPRE3, CLIP1, CAMSAP1/2/3, KIF2A, KIF2C, KIF18A, and DCTN1, among others.
What is the difference between microtubule plus-end and minus-end?
The plus-end is the fast-growing end where beta-tubulin is exposed and +TIPs bind; the minus-end is the slow-growing or stable end, often anchored and bound by -TIPs like CAMSAPs.
How do plus-end tracking proteins work?
Plus-end tracking proteins (+TIPs) recognize the plus-end and regulate microtubule dynamics, link microtubules to cellular structures, and mediate interactions with cargo. EB1 is a core +TIP that recruits other proteins.
What diseases are associated with microtubule end dysfunction?
Dysregulation of microtubule-end proteins is linked to cancer, neurodegenerative diseases such as Alzheimer's, and developmental disorders like tubulinopathies and hereditary spastic paraplegia.
How can I study microtubule ends in the lab?
Common methods include live-cell imaging of fluorescently tagged +TIPs, in vitro reconstitution with purified proteins, CRISPR knockout screens, and proteomics.
What is the role of CAMSAP proteins at microtubule minus-ends?
CAMSAP proteins bind to and stabilize microtubule minus-ends, protecting them from depolymerization and enabling non-centrosomal microtubule arrays.
Can CRISPR be used to study microtubule end genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect the functions of microtubule-end proteins and their roles in disease.
What are the research applications of microtubule end studies?
Research on microtubule ends informs our understanding of mitosis, intracellular transport, cell polarity, neuronal development, and provides targets for cancer therapy.
How does EDITGENE support microtubule end research?
EDITGENE provides custom CRISPR cell models (knockout, point mutation, knock-in, overexpression) and library screening with bioinformatics to study microtubule-end genes and mechanisms.
Conclusion
Microtubule ends (GO:1990752) are dynamic, protein-rich structures that are central to cytoskeletal function and cellular organization. The distinct properties of plus- and minus-ends, governed by specific tracking proteins and motors, enable precise control of microtubule dynamics in processes ranging from mitosis to neuronal development. Dysregulation of these proteins contributes to cancer, neurodegeneration, and developmental disorders, making microtubule ends important therapeutic targets. Continued research using advanced imaging, CRISPR models, and proteomics will further elucidate the molecular mechanisms at microtubule ends and their roles in health and disease.
References
- 1. Akhmanova A et al.. 2015. Microtubule minus-end-targeting proteins.. Curr Biol 25(4):R162-71 PMID: 25689915
- 2. Akhmanova A et al.. 2019. Microtubule minus-end regulation at a glance.. J Cell Sci 132(11) PMID: 31175152
- 3. van de Willige D et al.. 2016. Microtubule plus-end tracking proteins in neuronal development.. Cell Mol Life Sci 73(10):2053-77 PMID: 26969328
- 4. Jaworski J et al.. 2008. Microtubule plus-end tracking proteins in differentiated mammalian cells.. Int J Biochem Cell Biol 40(4):619-37 PMID: 18023603
- 5. Akhmanova A et al.. 2005. Microtubule plus-end-tracking proteins: mechanisms and functions.. Curr Opin Cell Biol 17(1):47-54 PMID: 15661518
- 6. Martin M et al.. 2018. Coming into Focus: Mechanisms of Microtubule Minus-End Organization.. Trends Cell Biol 28(7):574-588 PMID: 29571882
- 7. Galjart N. 2010. Plus-end-tracking proteins and their interactions at microtubule ends.. Curr Biol 20(12):R528-37 PMID: 20620909
- 8. Grishchuk EL. 2017. Biophysics of Microtubule End Coupling at the Kinetochore.. Prog Mol Subcell Biol 56:397-428 PMID: 28840247
